Home treatment of type VI mucopolysaccharidosis (Maroteaux‐Lamy syndrome) an alternative at this time of COVID‐19 pandemic: A case in Peru

We report a patient with mucopolysaccharidosis type VI, on long‐term enzyme replacement home therapy. Results support the efficacy and safety benefits, with additional advantage of home therapy to minimize the risk of community‐transmitted infections.

Detalles Bibliográficos
Autores principales: Cortez Miranda, Jenny Lucy, Blacido Trujillo, Lincoln, Liendo Chocano, María Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752495/
https://www.ncbi.nlm.nih.gov/pubmed/33363956
http://dx.doi.org/10.1002/ccr3.3420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752495/
https://www.ncbi.nlm.nih.gov/pubmed/33363956
http://dx.doi.org/10.1002/ccr3.3420

Ejemplares similares